Cellmid Ltd. (ASX:CDY)
Share Price and News
It is a developer of products to treat various cancers and chronic inflammatory diseases under the health care sector. The company was listed in 2005 under Pharmaceuticals, Biotechnology & Life Sciences industry group. The headquarter is based in Clarence Street, Sydney, Australia. The company is focused on rapidly scaling the multi-channel distribution of flagship, clinically proven product ranges in Asia, USA and Australia.